Cargando…
Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers
Increasing evidence suggests that tumor development requires not only oncogene/tumor suppressor mutations to drive the growth, survival, and metastasis but also metabolic adaptations to meet the increasing energy demand for rapid cellular expansion and to cope with the often nutritional and oxygen-d...
Autores principales: | Chen, Chia-Lin, Lin, Ching-Yu, Kung, Hsing-Jien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708687/ https://www.ncbi.nlm.nih.gov/pubmed/34948229 http://dx.doi.org/10.3390/ijms222413435 |
Ejemplares similares
-
Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells
por: Chen, Chia-Lin, et al.
Publicado: (2021) -
Targeting Tyrosine Kinases and Autophagy in Prostate Cancer
por: Kung, Hsing-Jien
Publicado: (2010) -
Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism
por: Shih, Jing-Wen, et al.
Publicado: (2015) -
Arginine Signaling and Cancer Metabolism
por: Chen, Chia-Lin, et al.
Publicado: (2021) -
TEAD4 as an Oncogene and a Mitochondrial Modulator
por: Hsu, Sheng-Chieh, et al.
Publicado: (2022)